
Topamax Lawsuit	Topamax Birth Defects	U.S. Supreme Court	33⅓% Contingent Fee	Contact Us
Lawyers are investigating claims against for serious birth defects caused by Topamax.	Learn about serious birth defects associated with Topamax, including cleft palate and cleft lip.	Read about how our landmark U.S. Supreme Court victory benefited consumers across America.	Many law firms charge percentage fees as high as 45%. We charge 33⅓% and we're paid only if we win your case and you collect.	If you took Topamax during pregnancy and your child has birth defects, contact us to discuss your legal rights.

Topamax News

We have compiled the latest news on Topamax. If your child has been harmed following the mother's use of Topamax during pregnancy and you would like more information about your legal rights, please contact us.

New Birth Defect Warning for Topamax	WebMd
	March 4, 2011

Taking the epilepsy drug topiramate (Topamax) during pregnancy raises the risk of oral cleft birth defects such as cleft lip and cleft palate, according to a new warning issued by the FDA.

New drug registry data show that the risk of oral birth defects is up to 16 times higher among women who took topiramate or its generic equivalents during pregnancy.

FDA: Topamax Ups Risk for Oral Birth Defects	Reuters
	March 4, 2011

An epilepsy drug also used to help prevent migraines can increase the risk for oral birth defects in babies born to women taking the medication, U.S. health officials said on Friday.

The Food and Drug Administration said new data shows expecting mothers taking the drug, sold generically and as Johnson & Johnson's Topamax, are about 20 times more likely to have their infants develop cleft lips or cleft palate deformities than those who are not treated.

Women Warned About Topamax	The New York Times
	March 4, 2011

The Food and Drug Administration warned women of child-bearing age that the epilepsy drug Topamax can increase the risk of birth defects around the mouth. Regulators said Friday that data showed a higher rate of cleft lip and cleft palate in children whose mothers were taking Topamax in the first trimester of pregnancy.

Infants who were exposed to the drug had a 1.4 percent rate of mouth defects, more than three times as high as that seen with other seizure medications. Johnson & Johnson and generic companies that market the drug, known as topiramate, will be required to add a stronger warning label about its effect on pregnancies.